日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual pancreatic carcinomas: clonally related or independent primaries?

双发胰腺癌:是克隆相关的原发癌还是独立的原发癌?

Schoenfeld, Joshua D; Ravichandran, Vignesh; Tarcan, Zeynep; Sahin-Ozkan, Hulya; Richards, Allison L; Bilani, Nadeem; Chou, Joanne F; O'Connor, Catherine A; McManamon, David; Varghese, Anna M; Keane, Fergus; D'Angelica, Michael I; Jarnagin, William R; Drebin, Jeffrey; Reidy-Lagunes, Diane; Wei, Alice C; Chalasani, Sree B; Balogun, Fiyinfolu; Park, Wungki; Yu, Kenneth H; Soares, Kevin; Donoghue, Mark T A; Iacobuzio-Donahue, Christine; Stadler, Zsofia K; Capanu, Marinela; Basturk, Olca; O'Reilly, Eileen M

Revisiting the Immune Frontier in Soft Tissue Sarcomas

重新审视软组织肉瘤的免疫前沿

Bilani, Nadeem; Al Akoum, Nourhane; Al-Marayaty, Rusul; Orlando, Sarah; Alexiev, Borislav; de Viveiros, Pedro Hermida; Pollack, Seth M

New Frontier in Cancer Immunotherapy: Sexual Dimorphism of Immune Response

癌症免疫疗法的新前沿:免疫反应的性别二态性

Bilani, Nadeem; Charbel, Nicole; Rizkallah, Joe; Sater, Sam; Kreidieh, Firas

Outcomes in Premenopausal Patients with HR+/HER2- Breast Cancer and Lymph Node Micrometastasis Based on the 21-Gene Recurrence Score

基于21基因复发评分的绝经前HR+/HER2-乳腺癌伴淋巴结微转移患者的预后

Bilani, Nadeem; Patel, Rima; Crowley, Fionnuala; Tiersten, Amy

Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?

21基因复发评分在HR+/HER2+乳腺癌中是否具有临床应用价值?

Bilani, Nadeem; Crowley, Fionnuala; Mohanna, Mohamed; Itani, Mira; Yaghi, Marita; Saravia, Diana; Jabbal, Iktej; Dominguez, Barbara; Liang, Hong; Nahleh, Zeina

Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes

HR+/HER2+小叶型乳腺癌的治疗和趋势并未反映出更好的治疗效果

Yaghi, Marita; Bilani, Nadeem; Dominguez, Barbara; Jabbal, Iktej Singh; Rivera, Carlos; Bou Zerdan, Maroun; Li, Hong; Saravia, Diana; Stone, Elizabeth; Nahleh, Zeina

Disparities in Metabolic Conditions and Cancer Characteristics among Hispanic Women with Breast Cancer: A Multi-Institutional Study

西班牙裔乳腺癌女性代谢状况和癌症特征的差异:一项多中心研究

Jabbal, Iktej S; Dwivedi, Alok; Bilani, Nadeem; Dominguez, Barbara; Botrus, Gehan; Nahleh, Zeina

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

三阴性乳腺癌:2021年分类和治疗进展

Bou Zerdan, Maroun; Ghorayeb, Tala; Saliba, Fares; Allam, Sabine; Bou Zerdan, Morgan; Yaghi, Marita; Bilani, Nadeem; Jaafar, Rola; Nahleh, Zeina

Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US

美国罕见三阴性乳腺癌的临床和人口统计学因素、治疗模式和总体生存率

Elimimian, Elizabeth B; Samuel, Thomas A; Liang, Hong; Elson, Leah; Bilani, Nadeem; Nahleh, Zeina A

Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis

免疫疗法对局限期小细胞肺癌患者总生存期的影响:一项基于国家癌症数据库的分析

Bilani, Nadeem; Alley, Evan; Elson, Leah; Nahleh, Zeina; Arteta-Bulos, Rafael